- Home
- OFIX
as 03-25-2025 3:32pm EST
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | LEWISVILLE |
| Market Cap: | 648.7M | IPO Year: | N/A |
| Target Price: | $23.33 | AVG Volume (30 days): | 253.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.08 - $20.73 | Next Earning Date: | 05-06-2025 |
| Revenue: | $799,491,000 | Revenue Growth: | 7.08% |
| Revenue Growth (this year): | 5.39% | Revenue Growth (next year): | 6.56% |
Stock Insider Trading Activity of Orthofix Medical Inc. (DE) (OFIX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gillespie Geoffrey C | OFIX | CAO | Mar 18 '25 | Sell | $16.60 | 296 | $4,913.60 | 42,521 | |
| Vitale Lucas | OFIX | CP&BOO | Mar 18 '25 | Sell | $16.60 | 4,287 | $71,164.20 | 135,317 | |
| Calafiore Massimo | OFIX | President & CEO | Mar 5 '25 | Buy | $17.43 | 9,914 | $172,801.02 | 222,404 | |
| Gillespie Geoffrey C | OFIX | CAO | Feb 3 '25 | Sell | $17.94 | 954 | $17,025.89 | 42,521 | |
| Andrews Julie | OFIX | CFO | Jan 16 '25 | Sell | $17.89 | 4,655 | $83,277.95 | 28,312 | |
| Gillespie Geoffrey C | OFIX | CAO | Jan 10 '25 | Sell | $16.99 | 475 | $8,065.20 | 42,521 | |
| Calafiore Massimo | OFIX | President & CEO | Jan 10 '25 | Sell | $16.99 | 19,281 | $327,375.69 | 124,151 | |
| Gillespie Geoffrey C | OFIX | CAO | Jan 7 '25 | Sell | $17.05 | 476 | $8,117.47 | 42,521 |
Latest Orthofix Medical Inc. (DE) News
OFIX Breaking Stock News: Dive into OFIX Ticker-Specific Updates for Smart Investing
MT Newswires
6 days ago
Orthofix Says Its Transverse Bone Transport System Receives US FDA, EU CE Mark Approval
Business Wire
6 days ago
Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System
Business Wire
13 days ago
Orthofix Announces Appointment of Vickie Capps to Board of Directors
CFO Dive
18 days ago
Orthofix’s fired execs’ lewd, ‘graphic’ texts surface in legal battle
Business Wire
22 days ago
Orthofix to Participate in the 37th Annual Roth Conference
Simply Wall St.
a month ago
Orthofix Medical Full Year 2024 Earnings: EPS Misses Expectations
Thomson Reuters StreetEvents
a month ago
Q4 2024 Orthofix Medical Inc Earnings Call
GuruFocus.com
a month ago
Orthofix Medical Inc (OFIX) Q4 2024 Earnings Call Highlights: Record Growth and Strategic Shifts
Compare OFIX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OFIX Orthofix Medical Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.